Skip to main content
. 2017 Jan-Feb;33(1):48–52. doi: 10.12669/pjms.331.12352

Table-III.

Treatment discontinuation and adverse events reported during the study period.

Variable n (%)
Discontinuation of treatment due to adverse event 2 (0.34)
Adverse Events
Fatigue 136 (23.7)
Nausea 6 (1.0)
Headache 54 (9.4)
Insomnia 1 (0.1)
Pruritus 3 (0.52)
Urticaria 1(0.1)
Anemia 49 (8.5)
Cough 2 (0.3)
Arthralgia 1 (0.1)